Certain reports investigating NSCLC patients have described an overexpressed SHH-GLI2 axis associated with poorer progression-free survival [49] as well as an overexpressed GLI-2 axis involved in cellular proliferation and apoptosis resistance in lung squamous cell carcinomas [50]. This evidence concerns the gene SHH and non-small cell lung carcinoma.